Clinical

Expanding ADNI: Alzheimer's Biomarker Study Embarks on Next Phase

Oct 12, 2016 at 05:37 pm by steve

The landmark Alzheimer's Disease Neuroimaging Initiative (ADNI) began in October 2004 with a goal of finding more sensitive and accurate methods to detect Alzheimer's disease.... Read More

From Genome to Bedside How Far Have We Come?

Oct 12, 2016 at 05:37 pm by steve

A wave of excitement swept through medical science in 2003 when the first sequencing of the human genome was completed. News stories were full of enthusiastic predictions of a.... Read More

Sequencing the DNA Profile of Patients with Specific Diseases

Oct 12, 2016 at 05:37 pm by steve

For most physicians, difficult conversations come with the territory. After the initial shock of hearing a serious diagnosis and absorbing what the prognosis could mean, the n.... Read More

Sequencing Cancer: HudsonAlpha Joins ORIEN Avatar Collaboration

Oct 12, 2016 at 05:37 pm by steve

For patients with advanced stage cancer, time is life. HudsonAlpha Institute for Biotechnology has joined 13 of the nation's top cancer research centers in the Oncology Resear.... Read More

New Therapy Turns Back Time for Menopausal Women

Oct 12, 2016 at 05:37 pm by steve

Almost half of women in the United States suffer from symptoms of declining estrogen, including the uncomfortable condition of vaginal atrophy. The atrophy causes thinning, dr.... Read More